Mesenchymal Stromal/Stem cells: Historical perspective and ongoing challenges
The potential of stem cell-based therapy was accompanied by high expectations and led, consequently, to an increase in clinical translational investments. Mesenchymal stem/stromal cells (MSCs) became the cell-based product most experimentally studied worldwide. However, uncertainties about the mechanisms and the in vivo identity of MSCs impose concerns about their large-scale use in regenerative medicine. This review comprises a historical summary on MSC, a critical discussion about their identity and function, and the ongoing challenges for their use in therapy and tissue bioengineering.
Copyright (c) 2020 Maria Isabel Doria Rossi, Danielle Cabral Bonfim
This work is licensed under a Creative Commons Attribution 4.0 International License.